These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17067603)

  • 41. Iron status and HFE mutations in first-degree relatives of patients with sporadic porphyria cutanea tarda, in a Mediterranean area.
    Garcia-Morillo JS; Lorca RR; Bernabeu-Wittel M; Garcia-Junco PS; Andreu EP; de la Fuente JC
    J Intern Med; 2005 Apr; 257(4):389-90; author reply 391-3. PubMed ID: 15788010
    [No Abstract]   [Full Text] [Related]  

  • 42. Semiquantitative and qualitative assessment of hepatic iron in patients with chronic viral hepatitis: relation with grading, staging and haemochromatosis mutations.
    Vergani A; Bovo G; Trombini P; Caronni N; Arosio C; Malosio I; Fossati L; Roffi L; Piperno A
    Ital J Gastroenterol Hepatol; 1999; 31(5):395-400. PubMed ID: 10470600
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Iron overload and prolonged ingestion of iron supplements: clinical features and mutation analysis of hemochromatosis-associated genes in four cases.
    Barton JC; Lee PL; West C; Bottomley SS
    Am J Hematol; 2006 Oct; 81(10):760-7. PubMed ID: 16838333
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Iron overload in acute myeloid leukemia patients is not related to HFE and TFR2 gene mutations.
    Veneri D; Franchini M; Zanetti F; Krampera M; de Matteis G; Pizzolo G
    Haematologica; 2003 Sep; 88(9):1069-70. PubMed ID: 12969816
    [No Abstract]   [Full Text] [Related]  

  • 45. Iron, HFE mutations, and hepatocellular carcinoma: is hepatic iron a carcinogen?
    Ioannou GN; Kowdley KV
    Clin Gastroenterol Hepatol; 2003 Jul; 1(4):246-8. PubMed ID: 15017663
    [No Abstract]   [Full Text] [Related]  

  • 46. HFE Mutations as risk factors in disease.
    Worwood M
    Best Pract Res Clin Haematol; 2002 Jun; 15(2):295-314. PubMed ID: 12401309
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The geography of HFE mutations: molecular diagnosis of haemochromatosis and the globalization of genetic testing.
    Salto-Tellez M; Siew-Chuan Koay E
    Eur J Hum Genet; 2004 Nov; 12(11):877-8. PubMed ID: 15340365
    [No Abstract]   [Full Text] [Related]  

  • 48. HFE, iron homeostasis and genetic hemochromatosis.
    Cazzola M
    Haematologica; 2000 Apr; 85(4):338-9. PubMed ID: 10756355
    [No Abstract]   [Full Text] [Related]  

  • 49. [Hereditary and acquired iron overload].
    de Korwin JD
    Nephrol Ther; 2006 Nov; 2 Suppl 5():S304-12. PubMed ID: 17373275
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic predisposition to iron overload: prevalence and phenotypic expression of hemochromatosis-associated HFE-C282Y gene mutation.
    Distante S
    Scand J Clin Lab Invest; 2006; 66(2):83-100. PubMed ID: 16537242
    [No Abstract]   [Full Text] [Related]  

  • 51. HFE mutations analysis of Turkish patients with nonalcoholic steatohepatitis.
    Simsek H; Balaban YH; Sümer H; Yilmaz E; Tatar G
    Dig Dis Sci; 2006 Oct; 51(10):1723-4. PubMed ID: 16964543
    [No Abstract]   [Full Text] [Related]  

  • 52. [Iron as comorbid factor in chronic hepatitis C].
    Erhardt A; Hauck K; Häussinger D
    Med Klin (Munich); 2003 Dec; 98(12):685-91. PubMed ID: 14685669
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of iron and HFE mutations on response to therapy in chronic hepatitis C: an ironic interaction?
    Alexander J; Kowdley KV
    Gastroenterology; 2006 Nov; 131(5):1635-8. PubMed ID: 17067603
    [No Abstract]   [Full Text] [Related]  

  • 54. HFE gene mutations prevent sustained virological response to interferon plus ribavirin in chronic hepatitis C patients with serum markers of iron overload.
    Coelho-Borges S; Cheinquer H; Cheinquer N; Krug L; Ashton-Prolla P
    Am J Gastroenterol; 2002 Jun; 97(6):1570-2. PubMed ID: 12094895
    [No Abstract]   [Full Text] [Related]  

  • 55. Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C.
    Bonkovsky HL; Naishadham D; Lambrecht RW; Chung RT; Hoefs JC; Nash SR; Rogers TE; Banner BF; Sterling RK; Donovan JA; Fontana RJ; Di Bisceglie AM; Ghany MG; Morishima C;
    Gastroenterology; 2006 Nov; 131(5):1440-51. PubMed ID: 17101320
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Iron overload and chronic hepatitis C: the role of HFE gene mutations.
    García Buey L; González Mateos F
    Rev Esp Enferm Dig; 2003 Dec; 95(12):819-28. PubMed ID: 14972003
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.